A Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial
| Status: | Completed |
|---|---|
| Conditions: | Cancer |
| Therapuetic Areas: | Oncology |
| Healthy: | No |
| Age Range: | 18 - Any |
| Updated: | 9/5/2018 |
| Start Date: | April 16, 2014 |
| End Date: | December 21, 2016 |
A Phase II Open-label Rollover Study for Subjects That Have Participated in an Astellas Sponsored Linsitinib Trial
The purpose of this study is to provide access to continued treatment for subjects who
participated in other Astellas sponsored trials and for whom the investigator feels the
subject may benefit from continued treatment.
participated in other Astellas sponsored trials and for whom the investigator feels the
subject may benefit from continued treatment.
Inclusion Criteria:
- Subject must currently be participating in an Astellas sponsored linsitinib trial that
has ended with respect to the overall study analysis.
- Subject must not have met criteria for discontinuation or have progressed on the
current linsitinib study in which they are participating.
- Subject must be deriving benefit from continued treatment.
We found this trial at
6
sites
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials